FOXP2 confers oncogenic effects in prostate cancer.
Zhu X, Chen C, Wei D, Xu Y, Liang S, Jia W, Li J, Qu Y, Zhai J, Zhang Y, Wu P, Hao Q, Zhang L, Zhang W, Yang X, Pan L, Qi R, Li Y, Wang F, Yi R, Yang Z, Wang J, Zhao Y.
Zhu X, et al. Among authors: li y, li j.
Elife. 2023 Sep 5;12:e81258. doi: 10.7554/eLife.81258.
Elife. 2023.
PMID: 37668356
Free PMC article.